⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49328 | 1.00 | — | — | |
| SCHEMBL16674608 | 1.00 | — | — | |
| SCHEMBL10663817 | 1.00 | HPGD (0.43) | — | |
| SCHEMBL1021742 | 0.97 | HPGD (0.41) | — | |
| SCHEMBL1023085 | 0.97 | HPGD (0.41) | — | |
| SCHEMBL7969703 | 0.97 | HPGD (0.41) | — | |
| SCHEMBL3151436 | 0.97 | HPGD (0.41) | — | |
| SCHEMBL64469 | 0.97 | HPGD (0.41) | — | |
| SCHEMBL11298939 | 0.97 | HPGD (0.41) | — | |
| SCHEMBL1022859 | 0.97 | HPGD (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 27809 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3929207-B1 | PEPTIDE FTTFTVT FOR USE IN TREATING FIBROSIS | UNIV TEXAS (US) | 2024-07-17 | — | — | EP | claimed |
| CN-118336119-A | Battery cell | 珠海冠宇电池股份有限公司 | 2024-07-12 | — | — | CN | claimed |
| CN-113874361-B | Compound with anticancer activity and preparation method thereof | 医药生命融合研究团 | 2024-07-12 | — | — | CN | claimed |
| WO-2024145931-A1 | SMALL MOLECULE INHIBITOR FOR β-CATENIN/BCL9 PROTEIN-PROTEIN INTERACTION AND USE THEREOF | 上海医药工业研究院有限公司 | 2024-07-11 | — | — | WO | claimed |
| US-20240228425-A1 | PREPARATION METHOD OF PILOCARPINE AND ITS INTERMEDIATE COMPOUNDS | ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | claimed |
| CN-118307621-A | Important intermediate for preparing chenodeoxycholic acid and synthesis method thereof | 苏州恩泰新材料科技有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118315657-A | Gel electrolyte, preparation method thereof and energy storage device | 深圳市合壹新能技术有限公司 | 2024-07-09 | — | — | CN | claimed |
| WO-2024140282-A1 | PREPARATION METHODS FOR PILOCARPINE AND INTERMEDIATE COMPOUND THEREOF | 浙江奥翔药业股份有限公司 | 2024-07-04 | — | — | WO | claimed |
| US-20240217969-A1 | SUBSTITUTED PYRROLE CARBOXAMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2024-07-04 | — | — | US | claimed |
| US-20240216904-A1 | ION EXCHANGER, METHOD FOR PRODUCING ION EXCHANGER, CATALYST HAVING PLATINUM-GROUP METAL ION SUPPORTED THEREON, AND METHOD FOR FORMING CARBON-CARBON BOND | ORGANO CORPORATION (JP) | 2024-07-04 | — | — | US | claimed |
| US-3984417-A | Method of producing active amino acid esters | AJINOMOTO CO., INC. (JA) | 1976-10-05 | — | — | US | claimed |
| US-3979399-A | ATARACTIC, ANALGESIC, HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1976-09-07 | — | — | US | claimed |
| US-3978063-A | 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-08-31 | — | — | US | claimed |
| US-3975532-A | ANALGESIC | ICI UNITED STATES INC. (US) | 1976-08-17 | — | — | US | claimed |
| US-3966746-A | ATARACTIC, ANALGESIC, HYPOTENSIVE | E. R. SQUIBB & SONS, INC. (US) | 1976-06-29 | — | — | US | claimed |
| US-3963731-A | TREATMENT OF GOUT AND HYPERURICEMIA | MERCK & CO., INC. (US) | 1976-06-15 | — | — | US | claimed |
| US-3948937-A | Pyrazole plant growth regulants | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-04-06 | — | — | US | claimed |
| US-3947577-A | 1,2,4-TRIAZOLES | MERCK & CO., INC. (US) | 1976-03-30 | — | — | US | claimed |
| US-3933783-A | Formation of peptide bonds in the presence of isonitriles | AJINOMOTO CO., INC. (JA) | 1976-01-20 | — | — | US | claimed |
| US-3932503-A | Benzenesulfonyl ureas | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-01-13 | — | — | US | claimed |